Literature DB >> 16316853

Application of USP inlet extensions to the TSI impactor system 3306/3320 using HFA 227 based solution metered dose inhalers.

Erik Mogalian1, Paul Brian Myrdal.   

Abstract

The objective of this study was to further evaluate the need for a vertical inlet extension when testing solution metered dose inhalers using the TSI Model 3306 Impactor Inlet in conjunction with the TSI Model 3320 Aerodynamic Particle Sizer (APS). The configurations tested using the TSI system were compared to baseline measurements that were performed using the Andersen Mark II 8-stage cascade impactor (ACI). Seven pressurized solution metered dose inhalers were tested using varied concentrations of beclomethasone dipropionate (BDP), ethanol, and HFA 227 propellant. The inhalers were tested with the cascade impactor, and with the TSI system. The TSI system had three different configurations as the manufacturer provided (0 cm) or with inlet extensions of 20 and 40 cm. The extensions were located between the USP inlet and the Model 3306 Impactor Inlet. There were no practical differences between each system for the stem, actuator, or USP inlet. The fine particle mass (aerodynamic mass < 4.7 microm) was affected by extension length and correlated well with the ACI when an extension was present. APS particle size measurements were unaffected by the extension lengths and correlated well to particle size determined from the ACI analysis. It has been confirmed that an inlet extension may be necessary for the TSI system in order to give mass results that correlate to the ACI, especially for formulations having significant concentrations of low volatility excipients. Additionally, the results generated from this study were used to evaluate the product performance of HFA 227 based solution formulations that contain varying concentrations of ethanol as a cosolvent.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316853     DOI: 10.1080/03639040500306211

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  4 in total

1.  Effect of oropharyngeal length in drug lung delivery via suspension pressurized metered dose inhalers.

Authors:  T Ehtezazi; D R Allanson; I D Jenkinson; C O'Callaghan
Journal:  Pharm Res       Date:  2006-05-26       Impact factor: 4.200

Review 2.  Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs).

Authors:  Jolyon Mitchell; Richard Bauer; Svetlana Lyapustina; Terrence Tougas; Volker Glaab
Journal:  AAPS PharmSciTech       Date:  2011-07-22       Impact factor: 3.246

Review 3.  Advances in metered dose inhaler technology: formulation development.

Authors:  Paul B Myrdal; Poonam Sheth; Stephen W Stein
Journal:  AAPS PharmSciTech       Date:  2014-01-23       Impact factor: 3.246

4.  Evaluation of the TSI aerosol impactor 3306/3321 system using a redesigned impactor stage with solution and suspension metered-dose inhalers.

Authors:  Julie A Harris; Stephen W Stein; Paul B Myrdal
Journal:  AAPS PharmSciTech       Date:  2006-03-10       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.